From StockStory: 2025-05-08 18:29:00

In Q1 CY2025, Astrana Health’s revenue rose 53.4% year on year to $620.4 million, but missed Wall Street’s expectations. The company reported a GAAP profit of $0.14 per share, 33.1% below analyst estimates. Despite reconfirming full-year revenue guidance of $2.6 billion, next quarter’s revenue guidance of $635 million fell short, causing the stock to drop 3.9%. With an average annualized revenue growth of 29% over the last five years, Astrana Health’s long-term sales performance is strong. However, its operating margin decreased to 3.3% in Q1, indicating rising expenses. Analysts expect EPS to grow 92.3% over the next 12 months.



Read more at StockStory: Astrana Health (NASDAQ:ASTH) Misses Q1 Revenue Estimates